vs
HALOZYME THERAPEUTICS, INC.（HALO）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
Rithm Capital Corp.的季度营收约是HALOZYME THERAPEUTICS, INC.的1.8倍（$828.2M vs $451.8M），Rithm Capital Corp.净利率更高（13.2% vs -31.3%，领先44.6%），Rithm Capital Corp.同比增速更快（508.5% vs 51.6%），过去两年HALOZYME THERAPEUTICS, INC.的营收复合增速更高（51.9% vs -17.9%）
Halozyme Therapeutics是一家美国生物技术企业，专注于肿瘤领域创新疗法研发，核心管线均针对肿瘤微环境进行靶向干预，致力于为全球癌症患者提供更安全高效的治疗选择。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
HALO vs RITM — 直观对比
营收规模更大
RITM
是对方的1.8倍
$451.8M
营收增速更快
RITM
高出456.9%
51.6%
净利率更高
RITM
高出44.6%
-31.3%
两年增速更快
HALO
近两年复合增速
-17.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $451.8M | $828.2M |
| 净利润 | $-141.6M | $109.5M |
| 毛利率 | 82.6% | — |
| 营业利润率 | -20.6% | 29.9% |
| 净利率 | -31.3% | 13.2% |
| 营收同比 | 51.6% | 508.5% |
| 净利润同比 | -203.3% | 27.7% |
| 每股收益（稀释后） | $-1.13 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HALORITM
| Q1 26 | — | $828.2M | ||
| Q4 25 | $451.8M | $1.5B | ||
| Q3 25 | $354.3M | $1.1B | ||
| Q2 25 | $325.7M | $1.2B | ||
| Q1 25 | $264.9M | $768.4M | ||
| Q4 24 | $298.0M | $2.1B | ||
| Q3 24 | $290.1M | $619.5M | ||
| Q2 24 | $231.4M | $1.2B |
净利润HALORITM
| Q1 26 | — | $109.5M | ||
| Q4 25 | $-141.6M | $85.0M | ||
| Q3 25 | $175.2M | $221.5M | ||
| Q2 25 | $165.2M | $311.7M | ||
| Q1 25 | $118.1M | $78.8M | ||
| Q4 24 | $137.0M | $290.2M | ||
| Q3 24 | $137.0M | $121.7M | ||
| Q2 24 | $93.2M | $235.6M |
毛利率HALORITM
| Q1 26 | — | — | ||
| Q4 25 | 82.6% | — | ||
| Q3 25 | 84.4% | — | ||
| Q2 25 | 85.8% | — | ||
| Q1 25 | 81.7% | — | ||
| Q4 24 | 85.9% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 82.9% | — |
营业利润率HALORITM
| Q1 26 | — | 29.9% | ||
| Q4 25 | -20.6% | 13.8% | ||
| Q3 25 | 61.5% | 21.4% | ||
| Q2 25 | 62.2% | 25.2% | ||
| Q1 25 | 53.4% | 7.4% | ||
| Q4 24 | 58.9% | 23.8% | ||
| Q3 24 | 56.3% | 7.3% | ||
| Q2 24 | 50.7% | 23.6% |
净利率HALORITM
| Q1 26 | — | 13.2% | ||
| Q4 25 | -31.3% | 5.7% | ||
| Q3 25 | 49.5% | 20.0% | ||
| Q2 25 | 50.7% | 25.6% | ||
| Q1 25 | 44.6% | 10.3% | ||
| Q4 24 | 46.0% | 14.0% | ||
| Q3 24 | 47.2% | 19.7% | ||
| Q2 24 | 40.3% | 19.2% |
每股收益（稀释后）HALORITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | $-1.13 | $0.09 | ||
| Q3 25 | $1.43 | $0.35 | ||
| Q2 25 | $1.33 | $0.53 | ||
| Q1 25 | $0.93 | $0.07 | ||
| Q4 24 | $1.06 | $0.50 | ||
| Q3 24 | $1.05 | $0.20 | ||
| Q2 24 | $0.72 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.8M | — |
| 总债务越低越好 | $2.1B | — |
| 股东权益账面价值 | $48.8M | $9.1B |
| 总资产 | $2.5B | $53.4B |
| 负债/权益比越低杠杆越低 | 43.89× | — |
8季度趋势，按日历期对齐
现金及短期投资HALORITM
| Q1 26 | — | — | ||
| Q4 25 | $133.8M | $1.8B | ||
| Q3 25 | $419.7M | $1.6B | ||
| Q2 25 | $61.9M | $1.6B | ||
| Q1 25 | $176.3M | $1.5B | ||
| Q4 24 | $115.8M | $1.5B | ||
| Q3 24 | $154.3M | $1.6B | ||
| Q2 24 | $187.9M | $1.2B |
总债务HALORITM
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $35.4B | ||
| Q3 25 | $1.5B | $32.2B | ||
| Q2 25 | $1.5B | $31.2B | ||
| Q1 25 | $1.5B | $32.2B | ||
| Q4 24 | $1.5B | $32.6B | ||
| Q3 24 | $1.5B | $29.6B | ||
| Q2 24 | $1.5B | $30.1B |
股东权益HALORITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | $48.8M | $8.4B | ||
| Q3 25 | $503.9M | $8.5B | ||
| Q2 25 | $332.7M | $7.9B | ||
| Q1 25 | $482.3M | $7.8B | ||
| Q4 24 | $363.8M | $7.8B | ||
| Q3 24 | $452.7M | $7.7B | ||
| Q2 24 | $289.4M | $7.3B |
总资产HALORITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | $2.5B | $53.1B | ||
| Q3 25 | $2.2B | $47.2B | ||
| Q2 25 | $2.1B | $44.3B | ||
| Q1 25 | $2.2B | $45.3B | ||
| Q4 24 | $2.1B | $46.0B | ||
| Q3 24 | $2.1B | $42.3B | ||
| Q2 24 | $2.0B | $42.0B |
负债/权益比HALORITM
| Q1 26 | — | — | ||
| Q4 25 | 43.89× | 4.20× | ||
| Q3 25 | 3.00× | 3.79× | ||
| Q2 25 | 4.54× | 3.92× | ||
| Q1 25 | 3.13× | 4.14× | ||
| Q4 24 | 4.14× | 4.18× | ||
| Q3 24 | 3.32× | 3.87× | ||
| Q2 24 | 5.19× | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $219.0M | — |
| 自由现金流经营现金流 - 资本支出 | $217.6M | — |
| 自由现金流率自由现金流/营收 | 48.2% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $644.6M | — |
8季度趋势，按日历期对齐
经营现金流HALORITM
| Q1 26 | — | — | ||
| Q4 25 | $219.0M | $-114.6M | ||
| Q3 25 | $178.6M | $-2.0B | ||
| Q2 25 | $99.7M | $-557.1M | ||
| Q1 25 | $154.2M | $1.4B | ||
| Q4 24 | $178.5M | $-1.8B | ||
| Q3 24 | $115.4M | $768.1M | ||
| Q2 24 | $55.8M | $-55.7M |
自由现金流HALORITM
| Q1 26 | — | — | ||
| Q4 25 | $217.6M | — | ||
| Q3 25 | $175.6M | — | ||
| Q2 25 | $98.1M | — | ||
| Q1 25 | $153.3M | — | ||
| Q4 24 | $175.4M | — | ||
| Q3 24 | $113.9M | — | ||
| Q2 24 | $53.2M | — |
自由现金流率HALORITM
| Q1 26 | — | — | ||
| Q4 25 | 48.2% | — | ||
| Q3 25 | 49.6% | — | ||
| Q2 25 | 30.1% | — | ||
| Q1 25 | 57.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 39.3% | — | ||
| Q2 24 | 23.0% | — |
资本支出强度HALORITM
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.1% | — |
现金转化率HALORITM
| Q1 26 | — | — | ||
| Q4 25 | — | -1.35× | ||
| Q3 25 | 1.02× | -9.22× | ||
| Q2 25 | 0.60× | -1.79× | ||
| Q1 25 | 1.31× | 18.03× | ||
| Q4 24 | 1.30× | -6.04× | ||
| Q3 24 | 0.84× | 6.31× | ||
| Q2 24 | 0.60× | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
